Vaginal mucosa adhesion sites

The vaginal mucosa adhesion sites refer to the physiological and biochemical interface of the vaginal epithelium and its overlying mucus layer, which serves as a critical substrate for the localization and retention of topically administered therapeutic agents [PubMed: 16439062]. This site is primarily composed of a non-keratinized stratified squamous epithelium and a protective mucus gel containing high-molecular-weight glycoproteins known as mucins, specifically MUC1, MUC4, MUC5B, and MUC5AC [NCBI: NBK542220]. These mucins provide the necessary functional groups, such as sialic acid and sulfonic acid residues, that facilitate mucoadhesion through hydrogen bonding, electrostatic interactions, and physical polymer chain entanglement [PubMed: 21969730]. While not a traditional molecular target like a receptor or enzyme, these adhesion sites are essential for the efficacy of mucoadhesive drug delivery systems used to treat conditions such as vulvovaginal candidiasis, bacterial vaginosis, and vaginal atrophy [PubMed: 15916922]. Furthermore, targeting these sites is a key strategy in the development of microbicides intended to prevent the transmission of sexually transmitted infections, including HIV [Science: 338.6105.303]. The interaction between mucoadhesive polymers, such as chitosan or polycarbophil, and the vaginal mucosa allows for prolonged drug release and improved bioavailability by overcoming the natural self-cleansing mechanisms of the vaginal tract [PubMed: 35214115].

Other names

Vaginal mucus layerVaginal epitheliumMucoadhesive interfaceVaginal mucosal surfaceVaginal mucoadhesive site

Mucoadhesion through physical entanglement, hydrogen bonding, and electrostatic interactions with mucin glycoproteins and epithelial cell surfaces.